It may be particularly beneficial for: Adults with Obesity or Overweight : Individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher with obesity-related health conditions, can benefit from Retatrutide treatment
Importantly, fewer serious adverse events were reported with semaglutide across all diuretic subgroups, reinforcing its potential as a disease-modifying therapy for HFpEF
Among patients not taking a sulfonylurea, blood glucose less than 54 mg/dL with or without symptoms occurred in 22 (7.1%) of 312 SAXENDA-treated patients and 7 (4.5%) of 157 placebo-treated patients
We generated four groups because the phenomenology of stress, anxiety, and depression share symptoms (Ramn-Arbus et al., 2020) and are also a reference for possible comorbidities, which are common
We understand that every journey is unique and support you with personalized solutions